연구동향 분석

소아알레르기 질환에서 류코트리엔조절제의 역할

최봉석 ( Bong Seok Choi ) 손명현 ( Myung Hyun Sohn ) 김규언 ( Kyu Earn Kim ) 2015년

논문상세정보
인용/피인용
' 소아알레르기 질환에서 류코트리엔조절제의 역할' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • allergic rhinitis
  • asthma
  • atopic dermatitis
  • leukotrieneantagonist
  • urticaria
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
655 0

0.0%

' 소아알레르기 질환에서 류코트리엔조절제의 역할' 의 참고문헌

  • 운동유발성 천식 환아에서 montelukast 효과
    김자형 천식 및 알레르기 22 (4) : 720 ~ 727 [2002]
  • Zileuton and atopic dermatitis
    Taşkapan MO Ann Allergy Asthma Immunol 87 : 162 ~ 163 [2001]
  • Therapeutic options in idiopathic chronic urticaria
    Mora PM Rev Alerg Mex 52 : 77 ~ 82 [2005]
  • The role of inhaled corticosteroids and montelukast in children with mild-moderate asthma : results of a systematic review with meta-analysis
    Castro-Rodriguez JA Arch Dis Child 95 : 365 ~ 370 [2010]
  • The EAACI/GA(2) LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
    Zuberbier T Allergy 69 : 868 ~ 887 [2014]
  • Skin responses to intradermal histamine and leukotrienes C4, D4, and E4 in patients with chronic idiopathic urticaria and in normal subjects
    Maxwell DL J Allergy Clin Immunol 86 : 759 ~ 765 [1990]
  • Risk of suicide attempt in asthmatic children and young adults prescribed leukotriene-modifying agents : a nested case-control study
    Schumock GT J Allergy Clin Immunol 130 : 368 ~ 375 [2012]
  • Reports of suicidality in clinical trials of montelukast
    Philip G J Allergy Clin Immunol 124 : 691 ~ 696.e6 [2009]
  • Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group
    Edelman JM Ann Intern Med 132 : 97 ~ 104 [2000]
  • Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast
    Pearlman DS Ann Allergy Asthma Immunol 97 : 98 ~ 104 [2006]
  • Montelukast treatment in children with moderately severe atopic dermatitis
    Ehlayel MS Eur Ann Allergy Clin Immunol 39 : 232 ~ 236 [2007]
  • Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids
    Phipatanakul W Ann Allergy Asthma Immunol 91 : 49 ~ 54 [2003]
  • Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial
    Bjermer L BMJ 327 : 891 ~ [2003]
  • Modulation of human airway smooth muscle migration by lipid mediators and Th-2 cytokines
    Parameswaran K Am J Respir Cell Mol Biol 37 : 240 ~ 247 [2007]
  • Leukotrienes and airway inflammation
    Okunishi K Biochim Biophys Acta 1810 : 1096 ~ 1102 [2011]
  • Japanese Guideline for Childhood Asthma 2014
    Hamasaki Y Allergol Int 63 : 335 ~ 356 [2014]
  • Increased urinary leukotriene E4 excretion in patients with atopic dermatitis
    Hishinuma T Br J Dermatol 144 : 19 ~ 23 [2001]
  • Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast
    Ratner PH Ann Allergy Asthma Immunol 90 : 536 ~ 542 [2003]
  • Enhanced releasability of prostaglandin E2 and leukotrienes B4 and C4 from leukocytes of patients with atopic eczema
    Ruzicka T Acta Derm Venereol 67 : 469 ~ 475 [1987]
  • Efficacy of zileuton controlled-release tablets administered twice daily in the treatment of moderate persistent asthma : a 3-month randomized controlled study
    Nelson H Ann Allergy Asthma Immunol 99 : 178 ~ 184 [2007]
  • Efficacy of leukotriene antagonists as concomitant therapy in allergic rhinitis
    Cingi C Laryngoscope 120 : 1718 ~ 1723 [2010]
  • Effects of montelukast on quality of life in patients with persistent allergic rhinitis
    Cingi C Otolaryngol Head Neck Surg 142 : 654 ~ 658 [2010]
  • Effects of montelukast and budesonide on airway responses and airway inflammation in asthma
    Leigh R Am J Respir Crit Care Med 166 : 1212 ~ 1217 [2002]
  • Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone
    Baumgartner RA Eur Respir J 21 : 123 ~ 128 [2003]
  • Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study
    Nettis E Clin Exp Allergy 34 : 1401 ~ 1407 [2004]
  • Correlation between cysteinyl leukotriene release from leukocytes and clinical response to a leukotriene inhibitor
    Terashima T Chest 122 : 1566 ~ 1570 [2002]
  • Azelastine nasal spray : a review of pharmacology and clinical efficacy in allergic and nonallergic rhinitis
    Lieberman PL Allergy Asthma Proc 24 : 95 ~ 105 [2003]
  • Analysis of behavior-related adverse experiences in clinical trials of montelukast
    Philip G J Allergy Clin Immunol 124 : 699 ~ 706.e8 [2009]
  • Accumulation of leukotriene C4 and histamine in human allergic skin reactions
    Talbot SF J Clin Invest 76 : 650 ~ 656 [1985]
  • A randomized, comparative, multicentric clinical trial to assess the efficacy and safety of zileuton extended-release tablets with montelukast sodium tablets in patients suffering from chronic persistent asthma
    Kubavat AH Am J Ther 20 : 154 ~ 162 [2013]
  • A double-blind, placebo-controlled trial of montelukast in adult atopic eczema
    Friedmann PS Clin Exp Allergy 37 : 1536 ~ 1540 [2007]
  • A double-blind non-inferiority clinical study of montelukast, a cysteinyl leukotriene receptor 1 antagonist, compared with pranlukast in patients with seasonal allergic rhinitis
    Okubo K Allergol Int 57 : 383 ~ 390 [2008]
  • A case of Churg-Strauss syndrome in association with leukotriene modifier therapy when oral corticosteroids were withdrawn in an asthmatic patient
    Cho JH J Asthma Allergy Clin Immunol 22 : 487 ~ 493 [2002]
  • 5-lipoxygenase and FLAP
    Peters-Golden M Prostaglandins Leukot Essent Fatty Acids 69 : 99 ~ 109 [2003]